Supernus Pharmaceuticals, Inc. (SUPN)
50.00
-0.26
(-0.52%)
USD |
NASDAQ |
Jan 16, 16:00
49.55
-0.45
(-0.90%)
Pre-Market: 08:39
Supernus Pharmaceuticals Total Liabilities (Quarterly): 370.09M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amphastar Pharmaceuticals, Inc. | 889.48M |
| BridgeBio Pharma, Inc. | 2.921B |
| Catalyst Pharmaceuticals, Inc. | 131.36M |
| Assembly Biosciences, Inc. | 57.30M |
| Viking Therapeutics, Inc. | 26.38M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.420B |
| Shareholders Equity (Quarterly) | 1.050B |
| Debt to Equity Ratio | 0.0402 |
| Current Ratio | 1.796 |
| Net Debt Paydown Yield | -0.02% |